India Denies Patent To Abraxis Cancer Drug Abraxane At Natco Request
India's Patent Office, acting on a petition by local drug maker Natco Pharma, denied a patent for Abraxis BioScience's drug Abraxane (paclitaxel) for treating cancer.
India's Patent Office, acting on a petition by local drug maker Natco Pharma, denied a patent for Abraxis BioScience's drug Abraxane (paclitaxel) for treating cancer.